Citation Results
CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation
Nature Reviews Clinical Oncology 4, 603 - 607 (2007) | doi:10.1038/ncponc0931.
CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation
Nature Reviews Clinical Oncology 4, 603 - 607 (2007) | doi:10.1038/ncponc0931.